Fig. 8From: Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer modelAlpha-camera images for the liver following IV administration of 225Ac-DOTA-anti-PD-L1-BC (67 kBq, 3 mg/kg). The scale is normalized so that the average intensity over time is set to 1Back to article page